NeoGenomics (NASDAQ: NEO) director sells 5,307 shares in Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NeoGenomics director Lynn A. Tetrault reported an open-market sale of 5,307 shares of Common Stock at $11.10 per share on June 15, 2026. After this transaction, she directly holds 86,115 Common shares.
She also indirectly holds 7,000 Common shares through a Lynn Tetrault Rollover IRA. In addition, she has 15,970 Restricted Stock Units tied to Common Stock and multiple stock option grants covering various numbers of underlying shares with exercise prices ranging from $8.10 to $41.76 and expirations between 2026 and 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 5,307 shares ($58,908)
Net Sell
12 txns
Insider
TETRAULT LYNN A.
Role
null
Sold
5,307 shs ($59K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,307 | $11.10 | $59K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 86,115 shares (Direct, null);
Stock Option (Right to Buy) — 2,136 shares (Direct, null);
Restricted Stock Unit — 15,970 shares (Direct, null);
Common Stock — 7,000 shares (Indirect, Lynn Tetrault Rollover IRA)
Footnotes (1)
- [object Object]
Key Figures
Shares sold: 5,307 shares
Sale price: $11.10 per share
Direct holdings after sale: 86,115 shares
+5 more
8 metrics
Shares sold
5,307 shares
Open-market or private sale of Common Stock on June 15, 2026
Sale price
$11.10 per share
Price received for 5,307 Common shares sold
Direct holdings after sale
86,115 shares
Common Stock directly owned following the June 15, 2026 sale
Indirect IRA holdings
7,000 shares
Common Stock held via Lynn Tetrault Rollover IRA
Restricted Stock Units
15,970 units
RSUs tied to Common Stock; once vested, not subject to expiration
Option exercise price
$7.28 per share
Stock option on 16,107 underlying Common shares, expiring June 1, 2035
Highest option exercise price
$41.76 per share
Stock option on 972 underlying Common shares, expiring October 11, 2028
Earliest option expiration
June 6, 2026
Stock option on 2,136 underlying Common shares at $22.52 exercise price
Key Terms
Restricted Stock Unit, Stock Option (Right to Buy), open-market sale, indirect ownership, +2 more
6 terms
Restricted Stock Unit financial
"The security title is listed as "Restricted Stock Unit" with underlying Common Stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (Right to Buy) financial
"Multiple entries show "Stock Option (Right to Buy)" with specified exercise prices."
open-market sale financial
"The transaction_action field describes the event as an "open-market sale"."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
"A Common Stock holding is marked with ownership_type "indirect" via a Rollover IRA."
Rollover IRA financial
"Nature of ownership notes "Lynn Tetrault Rollover IRA" for 7,000 shares."
exercise price financial
"Each stock option record includes a "conversion_or_exercise_price" field."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What equity awards and options does the NeoGenomics (NEO) director still have?
She holds 15,970 Restricted Stock Units tied to NeoGenomics Common Stock and multiple stock options. These options cover various underlying share amounts with exercise prices between $8.10 and $41.76 and expiration dates ranging from 2026 through 2036.
Is the NeoGenomics (NEO) Form 4 sale by Lynn A. Tetrault a buy or sell transaction?
The Form 4 shows a sell transaction. It reports an open-market or private sale of 5,307 shares of NeoGenomics Common Stock, coded as a sale transaction, with no corresponding purchase or option exercise reported in this filing.